Current devices and interventions in mitral regurgitation

Benedikt Koell; Daniel Kalbacher; Edith Lubos

doi:10.1007/s00059-021-05055-w

Current devices and interventions in mitral regurgitation

Standard

Current devices and interventions in mitral regurgitation. / Koell, Benedikt ; Kalbacher, Daniel ; Lubos, Edith.

In: HERZ, Vol. 46, No. 5, 10.2021, p. 419-428.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Koell, B , Kalbacher, D & Lubos, E 2021, 'Current devices and interventions in mitral regurgitation', HERZ, vol. 46, no. 5, pp. 419-428. https://doi.org/10.1007/s00059-021-05055-w

APA

Koell, B., Kalbacher, D., & Lubos, E. (2021). Current devices and interventions in mitral regurgitation. HERZ, 46(5), 419-428. https://doi.org/10.1007/s00059-021-05055-w

Vancouver

Koell B , Kalbacher D , Lubos E. Current devices and interventions in mitral regurgitation. HERZ. 2021 Oct;46(5):419-428. https://doi.org/10.1007/s00059-021-05055-w

Bibtex

@article{6f07a670b87648fb82436d3cdf47ddd7,

title = "Current devices and interventions in mitral regurgitation",

abstract = "Mitral regurgitation (MR) is the most common valvular disease. With a rising incidence in older age, the prevalence of relevant comorbidities inevitably increases. Considering the constantly aging population with high surgical risk, transcatheter therapy of MR is gaining increasing importance. Interventional therapy of either primary or secondary MR represents an alternative to pure drug or surgical therapy. With mitral valve transcatheter edge-to-edge repair, a well-established treatment has evolved in the past two decades. In addition, direct or indirect annuloplasty and ultimately transcatheter mitral valve implantation further expand the armamentarium. The current broad spectrum of interventional therapy options allows for patient-oriented therapy individually targeting different MR pathologies. This review discusses the current landscape of transcatheter therapies for relevant MR.",

keywords = "Aged, Aortic Valve, Cardiac Catheterization, Heart Valve Prosthesis Implantation, Humans, Mitral Valve/diagnostic imaging, Mitral Valve Annuloplasty, Mitral Valve Insufficiency/surgery, Treatment Outcome",

author = "Benedikt Koell and Daniel Kalbacher and Edith Lubos",

note = "{\textcopyright} 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2021",

month = oct,

doi = "10.1007/s00059-021-05055-w",

language = "English",

volume = "46",

pages = "419--428",

journal = "HERZ",

issn = "0340-9937",

publisher = "Urban und Vogel",

number = "5",

}

RIS

TY - JOUR

T1 - Current devices and interventions in mitral regurgitation

AU - Koell, Benedikt

AU - Kalbacher, Daniel

AU - Lubos, Edith

PY - 2021/10

Y1 - 2021/10

N2 - Mitral regurgitation (MR) is the most common valvular disease. With a rising incidence in older age, the prevalence of relevant comorbidities inevitably increases. Considering the constantly aging population with high surgical risk, transcatheter therapy of MR is gaining increasing importance. Interventional therapy of either primary or secondary MR represents an alternative to pure drug or surgical therapy. With mitral valve transcatheter edge-to-edge repair, a well-established treatment has evolved in the past two decades. In addition, direct or indirect annuloplasty and ultimately transcatheter mitral valve implantation further expand the armamentarium. The current broad spectrum of interventional therapy options allows for patient-oriented therapy individually targeting different MR pathologies. This review discusses the current landscape of transcatheter therapies for relevant MR.

AB - Mitral regurgitation (MR) is the most common valvular disease. With a rising incidence in older age, the prevalence of relevant comorbidities inevitably increases. Considering the constantly aging population with high surgical risk, transcatheter therapy of MR is gaining increasing importance. Interventional therapy of either primary or secondary MR represents an alternative to pure drug or surgical therapy. With mitral valve transcatheter edge-to-edge repair, a well-established treatment has evolved in the past two decades. In addition, direct or indirect annuloplasty and ultimately transcatheter mitral valve implantation further expand the armamentarium. The current broad spectrum of interventional therapy options allows for patient-oriented therapy individually targeting different MR pathologies. This review discusses the current landscape of transcatheter therapies for relevant MR.

KW - Aged

KW - Aortic Valve

KW - Cardiac Catheterization

KW - Heart Valve Prosthesis Implantation

KW - Humans

KW - Mitral Valve/diagnostic imaging

KW - Mitral Valve Annuloplasty

KW - Mitral Valve Insufficiency/surgery

KW - Treatment Outcome

U2 - 10.1007/s00059-021-05055-w

DO - 10.1007/s00059-021-05055-w

M3 - SCORING: Review article

C2 - 34398248

VL - 46

SP - 419

EP - 428

JO - HERZ

JF - HERZ

SN - 0340-9937

IS - 5

ER -